US Stocks
/
Veru Inc. Share Price
Veru Inc. Share Price

Veru Inc. Share Price

NASDAQ: VERU | Micro Cap
$2.43
+$0.32 (15.17%) Last updated on 16 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Veru Inc. Stock Performance

Open
$2.12
Prev. Close
$2.11
Circuit Range
N/A
Day Range
$2.12 - $2.46
Year Range
$2.06 - $7.23
Volume
6,193
Average Traded
$2.26

Veru Inc. Share Price Today

As of 16 October 2026, Veru Inc.'s share price is $2.43. The stock opened at $2.12, compared to its previous close of $2.11. During today's trading session, Veru Inc.'s share price traded between $2.12 and $2.46, with an average price of $2.29. Over the past 52 weeks, the stock has recorded a high of $7.23 and a low of $2.06. In terms of performance, Veru Inc.'s share price has risen by 7.52% over the last six months and is down 18.04% on a year-on-year basis.

Veru Inc. Share Price Chart

$2.12$2.46
L
Show Current Price
H

Veru Inc. Stock Fundamentals & Key Indicators

Market Cap
$35.59M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.80
Revenue (TTM)
$0.00
Return On Equity (TTM)
-47.96%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-582.07%

Veru Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit$1.45-$5.33-$2.74-$6.99
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-467.59%48.59%-155.11%

Veru Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$39.35$16.30$0.00$0.00
Net Profit-$83.78-$93.15-$37.80-$22.73
Net Profit Margin-212.91%-571.47%N/AN/A
Income ChangeN/A-11.18%59.42%39.87%

About Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Veru Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.61
$2.44
-8.79%
Sep 2026
$2.82
$2.67
-2.73%
Aug 2026
$2.26
$2.75
+23.04%
Jul 2026
$3.15
$2.23
-28.82%
Jun 2026
$2.28
$3.14
+33.33%
May 2026
$2.26
$2.35
+4.20%
Apr 2026
$2.30
$2.26
+1.35%
Mar 2026
$2.50
$2.23
-12.55%
Feb 2026
$2.54
$2.55
+0.79%
Jan 2026
$2.18
$2.53
+18.78%
Dec 2025
$2.48
$2.13
-14.11%
Nov 2025
$2.95
$2.48
-16.36%

VERU Share Price FAQs

What is Veru Inc. share price today?

chevron-up
Veru Inc. share price today is $2.43 as on October 16, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Veru Inc. stock?

chevron-up
The 52 week high of Veru Inc. stock is $7.23, while the 52 week low is $2.06 as of 16 Oct '26.

What is VERU's market capitalisation today?

chevron-up
VERU market capitalisation is $35.59M as of October 16, 2026, at 10:44 am IST.

What is VERU's net income for the last quarter?

chevron-up
VERU's net income for the last quarter is -6.99B USD.

What is the 5 year returns of VERU?

chevron-up
The 5 year returns of VERU is -70.26% as on 16 Oct '26.

What is the high & low stock price of VERU today?

chevron-up
VERU stock price hit a high of $2.46 and low of $2.12 as of 16 Oct '26.

Can I buy VERU shares in India?

chevron-up
Yes. You can buy VERU in India by opening an international trading account.